The Kaertor Foundation has officially joined the Funders Network of REMEDi4ALL, a European initiative funded by the Horizon Europe program that seeks to transform the drug repositioning ecosystem by accelerating the development of effective, safe and accessible therapies for diseases with unmet medical needs.

AN INNOVATIVE AND COLLABORATIVE APPROACH

Drug repositioning-identifying new therapeutic indications for existing drugs-represents an agile and cost-effective route to traditional new drug development. This approach holds particular promise for rare, ultra-rare and other neglected diseases, where the lack of effective treatments remains a troubling reality.

The incorporation of the Kaertor Foundation as a REMEDi4ALL partner reinforces our commitment to translational science, open innovation and results-oriented public-private collaboration. Our experience driving drug discovery and early drug development projects through strategic alliances positions us as a key player within this multidisciplinary consortium of 32 leading European organizations.

A NETWORK TO TRANSFORM ACCESS TO MEDICINES

REMEDi4ALL is building a comprehensive platform that will provide scientific, regulatory, methodological and financial support to repositioning projects at any stage of development and therapeutic area. It also promotes the creation of a global community that fosters the exchange of knowledge, the training of new professionals and the development of public policies that favor equitable access to reused medicines.

The Kaertor Foundation thus joins a collective effort to make drug repositioning a major avenue of therapeutic innovation, contributing to the sustainability of health systems and improving the lives of millions of people in Europe and the world.

Translated with DeepL.com (free version)